Eli Lilly Zepbound Cost 2025. Eli lilly garnered widespread praise tuesday for launching discounted versions of its blockbuster obesity drug zepbound. Health care costs are set to rise 9% in 2025, driven by specialty drugs and inflation.
Eli lilly’s zepbound is challenging wegovy in the obesity market, while u.s. Could be one of the biggest cost drivers for health insurers, employers and government health programs that cover it this.